Individuals who administered commonly used weight management medications (WMM) regained weight in less than two years after they stopped using the drugs, according to a Jan. 7 peer-reviewed study published in the BMJ Journal.
The research involved studies that analyzed various types of WMMs, including “newer and more effective” incretin mimetics such as semaglutide and tirzepatide medications. Popular weight loss drugs Ozempic and Wegovy are semaglutide medications, while Mounjaro and Zepbound are tirzepatide-based.
